Classification | Prescription drugs |
---|---|
Active Ingredients | Octreotide acetate 22.4 mg/mL (equivalent to 20 mg of octreotide base) or 33.6 mg/mL (equivalent to 30 mg of octreotide base) |
Efficacy and Effect | 1. Acromegaly 2. Carcinoid tumors 3. Vasoactive Intestinal Peptide Tumors |
Packing Unit | 20 mg: 1 vial with attached ampoule for solvent / box (not for sale in Korea) 30 mg: 1 vial with attached ampoule for solvent/ box (not for sale in Korea) |
Storage Method | Store between 2 and 8°C. Keep in the tight container and protect from light. |
Shelf Life | 36 months from manufacturing date |